Program to support pregnant women facing domestic violence in China
Testing the Domestic Violence Enhanced Perinatal Care in China
This study is trying out a new program to help pregnant women in China who are dealing with domestic violence, to see if it can improve their health and safety.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | Female |
| Sponsor | University of Texas at Austin Academic / other |
| Locations | 1 site (Jinan, Shandong) |
| Trial ID | NCT05388565 on ClinicalTrials.gov |
What this trial studies
This project addresses intimate partner violence (IPV) against pregnant women in China, a vulnerable population that has been largely underserved. It adapts the Domestic Violence Enhanced Home Visitation Program (DOVE) from the United States to the Chinese context, aiming to educate and empower women about IPV and improve maternal and infant health. The study will test the feasibility and acceptability of this intervention in two perinatal clinics, using a randomized control design to assess its impact on reducing IPV and enhancing health outcomes.
Who should consider this trial
Good fit: Ideal candidates for this study are pregnant women in early pregnancy who have experienced intimate partner violence within the past year.
Not a fit: Patients who are unable to read and understand Chinese will not benefit from this study due to the intervention's educational components.
Why it matters
Potential benefit: If successful, this program could significantly improve the health and safety of pregnant women and their infants by reducing the incidence of intimate partner violence.
How similar studies have performed: While this approach is novel in China, similar interventions in other countries have shown effectiveness in addressing intimate partner violence during the perinatal period.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Being in early pregnancy (less than 13 weeks gestation) and screened positive for IPV in the year before pregnancy or during the current pregnancy. Exclusion Criteria: * Women who are not able to read and understand Chinese.
Where this trial is running
Jinan, Shandong
- Shandong University — Jinan, Shandong, China (Recruiting)
Study contacts
- Study coordinator: Fenglin Cao, MD
- Email: caofenglin2008@126.com
- Phone: 13065093172
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.